Top Abstract Purchase Related
Home
>
Node
>
Subnode

Series on pharmacology in practice: 1. Drugs that alter mood. I. Tricyclic agents and monoamine oxidase inhibitors

Rosenbaum, A.H.; Maruta, T.; Richelson, E.

Mayo Clinic Proceedings 54(5): 335-344

1979

ISSN/ISBN: 0025-6196
PMID: 372690
Document Number: 142491
In the last 20 years, the treatment of mood disorders has advanced immeasurably. We now have relatively safe and effective agents for the treatment of depression and mania. This review discusses two types of agents that elevate mood--tricyclic antidepressants and monoamine oxidase inhibitors--including the indications for their use and their modes of action, pharmacokinetics, side effects, and drug interactions.

Document emailed within 1 workday
Secure & encrypted payments

Pitchot, W.; Scantamburlo, G.; Ansseau, M. 2011: Tricyclic antidepressants and monoamine oxidase inhibitors - do they still have a role in the treatment of depression? Revue Medicale de Liege 66(3): 144-152
Goldman, L.S.; Alexander, R.C.; Luchins, D.J. 1986: Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects Journal of Clinical Psychiatry 47(5): 225-229
Finberg, J.P. 1995: Pharmacology of reversible and selective inhibitors of monoamine oxidase type A Acta Psychiatrica Scandinavica. Supplementum 386: 8-13
Fisar, Z.; Hroudová, J.; Raboch, J.í 2010: Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers Neuro Endocrinology Letters 31(5): 645-656
Grant, E.C.; Pryse-Davies, J. 1968: Effect of oral contraceptives on depressive mood changes and on endometrial monoamine oxidase and phosphatases British Medical Journal 3(5621): 777-780
Larsen, J.K. 1981: Monoamine oxidase inhibitors Ugeskrift for Laeger 143(24): 1549-1552
Garcia, J.A. 1971: Monoamine oxidase inhibitors Revista Brasileira de Medicina 28(4): 143-146
Arai, Y.; Matsumoto, K.; Kamijo, K. 1972: Monoamine oxidase. 16. Purification of monoamine oxidase from beef liver mitochondria and its enzymatic properties Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 68(4): 400-409
Pare, C.M. 1963: Potentiation of Monoamine-Oxidase Inhibitors by Tryptophan Lancet 2(7306): 527-528
O'Brien, S.; McKeon, P. 1989: Monoamine oxidase inhibitors--new insights into old problems Irish Medical Journal 82(4): 146-147
Kooy, A.; Peters-Romeyn, B.M.; van Gool, A.R. 1993: Monoamine oxidase inhibitors: poisoning and interactions Nederlands Tijdschrift Voor Geneeskunde 137(38): 1910-1914
Nabatame, E. 1971: Monoamine oxidase. 12. Substrate specificity of monoamine oxidase in the rabbit brain and liver Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 67(4): 374-386
Fallon, B.; Foote, B.; Walsh, B.T.; Roose, S.P. 1988: 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors Journal of Clinical Psychiatry 49(4): 163-165
Lippmann, S.B.; Manshadi, M.S.; Gultekin, A. 1985: Monoamine oxidase inhibitors for depressed cardiac patients Journal of Clinical Psychiatry 46(12): 545-546
Burrows, D. 1989: An overview of monoamine oxidase inhibitors. Introductory remarks Journal of Neural Transmission. Supplementum 28: 1-3
Robinson, D.S. 1986: New perspectives on long-standing issues: the monoamine oxidase inhibitors Psychopharmacology Bulletin 22(1): 12-15
Maeda, I.; Ueda, T.; Koide, R.; Inatomi, M.; Fukado, Y.; Uchida, E.; Oguchi, K.; Yasuhara, H. 1988: Ocular hypotensive effects of monoamine oxidase-A inhibitors in rabbit Japanese Journal of Ophthalmology 32(2): 211-218
Medvedev, A.E.; Ivanov, A.S.; Veselovsky, A.V. 2000: Selective inhibitors and computer modelling of the active site of monoamine oxidase Neurobiology 8(2): 201-214
Martin, Y.C.; Biel, J.H. 1974: Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase Advances in Biochemical Psychopharmacology 12(0): 37-48
Cockhill, L.A.; Remick, R.A. 1987: Blood pressure effects of monoamine oxidase inhibitors--the highs and lows Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 32(9): 803-808